Hwang J S, Lai K H, Lo G H, Wang E M, Wang N M, Cheng J S, Peng N J, Hwang R L, Chang C F
Department of Medicine, Veterans General Hospital-Kaohsiung, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1996 Mar;57(3):177-83.
Dysfunction of the sphincter of Oddi (SOD) is one of the causes of postcholecystectomy syndrome and biliary pain. Endoscopic sphincterotomy (EST) is recommended in some patients refractory to conservative treatment. This study was designed to evaluate the efficacy of, and complications from EST in patients with SOD.
Between 1990 and 1993, 24 patients clinically diagnosed as having papillary stenosis were treated by endoscopic sphincterotomy. All patients had dilated common bile duct (CBD) in addition to 1) elevation of transaminases and alkaline phosphatase (n = 13); 2) elevation of transaminases and serum amylase (n = 4); 3) normal liver enzymes but delayed biliary emptying on quantitative hepatobiliary scintigraphy (QHS) (n = 7). No CBD stones, organic obstruction or other disorders were found in these patients.
EST was successfully performed in 24 patients. One patient had minor hemorrhage and one patient developed pancreatitis after EST. Twenty-two of the 24 patients (91.7%) were symptomatically improved before discharge. Twenty-one patients were regularly followed over a median period of 18 months (range 5-36) after EST. Two patients with symptom had recurrence at five and eight month follow up because of restenosis of papilla; another two patients with recurrent biliary symptoms, but the sphincter of Oddi remained wide open. Seventeen of 21 regularly followed patients were symptom free after the median 18-month follow up.
EST is an effective and safe modality for treatment of sphincter of Oddi dysfunction.
Oddi括约肌(SOD)功能障碍是胆囊切除术后综合征和胆绞痛的病因之一。对于一些保守治疗无效的患者,建议行内镜括约肌切开术(EST)。本研究旨在评估EST治疗SOD患者的疗效及并发症。
1990年至1993年间,24例临床诊断为乳头狭窄的患者接受了内镜括约肌切开术治疗。所有患者除具备以下情况外,均有胆总管(CBD)扩张:1)转氨酶和碱性磷酸酶升高(n = 13);2)转氨酶和血清淀粉酶升高(n = 4);3)肝酶正常但定量肝胆闪烁显像(QHS)显示胆汁排空延迟(n = 7)。这些患者未发现CBD结石、器质性梗阻或其他疾病。
24例患者EST均成功完成。1例患者术后出现少量出血,1例患者术后发生胰腺炎。24例患者中有22例(91.7%)在出院前症状改善。21例患者在EST后接受了为期18个月(范围5 - 36个月)的定期随访。2例有症状的患者在随访5个月和8个月时因乳头再狭窄而复发;另外2例有复发性胆绞痛症状,但Oddi括约肌仍保持开放。21例定期随访的患者中,17例在中位随访18个月后无症状。
EST是治疗Oddi括约肌功能障碍的一种有效且安全的方法。